Humana (HUM) Stock Forecast & Price Target

Humana
Bull Case

Here are some ways that investors could benefit from investing in Humana Inc.:

• Humana Inc. recently beat earnings expectations, reporting $7.61 in earnings per share for the quarter ended July 29, 2026, which exceeded the consensus estimate of $7.27 by $0.34, signaling strong operational performance and profitability that may attract value-oriented investors.
• The stock has demonstrated significant momentum, trading at a current price of $385.82 as of September 19, 2026, which represents a substantial recovery from its 52-week low of $163.11 and suggests that the market is increasingly confident in the company's turnaround and growth trajectory.
• Humana Inc. has received positive analyst attention, including an upgrade to a "Buy" rating by Wall Street Zen and an "Outperform" rating from Evercore with a $480.00 price target, indicating that sell-side analysts see potential for further upside in the stock price relative to its current level.
• Institutional investors have been increasing their stakes in the company, with firms like Tidal Investments LLC raising their position by 24.5% and The Manufacturers Life Insurance Company growing its stake by 10.5% in the second quarter, suggesting that large capital allocators are confident in the long-term stability and growth of Humana Inc.
• The company's revenue growth has been robust, with quarterly revenue up 26.2% year-over-year to $40.89 billion, indicating that Humana Inc. is successfully expanding its business and capturing market share in the healthcare insurance sector.